You guys might have jumped on management a bit quick here.
Its a renounceable issue... ie. the rights can be traded on-market.
2 for 5 @ 6.5c, with entitlements up for grabs for buyers till the end of the week... AND... a big juicy carrot in assay results of some exciting visuals by weeks end.
Could be a lot worse imo.
Who knows, might even see the stock rise short-term.
:)
